ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258825.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.001193575	Sensitive
ENSG00000258825.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.023498144	Sensitive